Factors Associated With Adherence To Long-Acting Inhaled Therapies Among Patients With COPD

被引：0
|
作者：
Cecere, L. M.
Slatore, C. G.
Uman, J.
Evans, L.
Udris, E. M.
Bryson, C. L.
Au, D. H.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2259
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
    Wang, Cheng-Yi
    Lin, You Shuei
    Wang, Ya-Hui
    Lai, Chih-Cheng
    Wang, Hao-Chien
    Chen, Likwang
    Yu, Chong-Jen
    Perng, Diahn-Warng
    Cheng, Shih-Lung
    Hsu, Jeng-Yuan
    Hsu, Wu-Huei
    Tsai, Ying-Huang
    Hsiue, Tzuen-Ren
    Lin, Meng-Chih
    Lin, Hen-, I
    Chang, Yeun-Chung
    Yang, Ueng-Cheng
    Chen, Chung-Ming
    Lin, Cing-Syong
    Wei, Yu-Feng
    Chong, Inn-Wen
    Chen, Chung-Yu
    AGING-US, 2019, 11 (17): : 6863 - 6871
  • [32] Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
    Oba, Yuji
    Chandran, Arul V.
    Devasahayam, Joe V.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 677 - 685
  • [33] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
    Mapel, Douglas W.
    Hurley, Judith S.
    Dalal, Anand A.
    Blanchette, Christopher M.
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103
  • [34] Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
    Pavord, Ian D.
    Lettis, Sally
    Locantore, Nicholas
    Pascoe, Steve
    Jones, Paul W.
    Wedzicha, Jadwiga A.
    Barnes, Neil C.
    THORAX, 2016, 71 (02) : 118 - 125
  • [35] Long-acting bronchodilators in COPD
    Sears, Malcolm R.
    CHEST, 2008, 133 (05) : 1057 - 1058
  • [36] Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD
    McNicholas, WT
    Calverley, PMA
    Lee, A
    Edwards, JC
    EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 825 - 831
  • [37] The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
    Hanania, Nicola A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (03) : 540 - 550
  • [38] Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
    Alphs, Larry
    Nasrallah, Henry A.
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Gopal, Srihari
    Hough, David
    Turkoz, Ibrahim
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 202 - 209
  • [39] Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
    Peng, Yating
    Duan, Jiaxi
    Li, Xin
    Zeng, Yuqin
    Zhou, Zijing
    Deng, Minghua
    Ouyang, Ruoyun
    Chen, Yan
    Cai, Shan
    Chen, Ping
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 2697 - 2706
  • [40] Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD
    Chang, Ting-Yu
    Chien, Jung-Yien
    Wu, Chung-Hsuen
    Dong, Yaa-Hui
    Lin, Fang-Ju
    CHEST, 2020, 157 (05) : 1117 - 1129
12345